NTX-001 is a potentially transformative adjunctive treatment for peripheral nerve injuries, using a propriety system for the reconnection of severed…
Continue ReadingNew Rhein Healthcare Investors invites you to join us for our event, Investing in Healthcare and Life Science Innovations, in Ghent, Belgium, on…
Continue ReadingPHILADELPHIA, June 10, 2019 /PRNewswire/ -- New Rhein Healthcare Investors, a Philadelphia based private equity manager focused on healthcare therapeutics and medical devices,…
Continue ReadingNew Rhein announces it's Inaugural Industry Day 2019! The event will include company presentations and fireside chats with senior pharma…
Continue ReadingLAFAYETTE, Colo., Dec. 19, 2018 /PRNewswire/ -- Neuraptive Therapeutics, Inc. (Neuraptive) announced today that it has secured a $11.5 million Series A equity financing which remains…
Continue Reading
